A Mild Covid Christmas

It finally got me. Last week I tested positive for Covid. For what it’s worth, I basically consider the virus to be endemic at this point. My behavior is (and has been) back to pre-pandemic normal. I’ve gone to sporting events, social events, and tried (keyword) to make it to Orangetheory Fitness 2x or 3x...
Continue reading...

My Time in Grad School

I blinked and it was over. It was three years, two degrees, a marriage, and a baby. My time in grad school was, of course, defined (mostly) by the pandemic, but it also proved to me that “I could do it.” …I need to eyeroll a little because I graduated twice… Way back in 2018,...
Continue reading...

If Vertex Has Such a Commanding Hold on the CFTR Modulator Market, Why Are Other Drug Makers Joining the Race?

With news of the emerging biotech company, Sionna, coming out of stealth yesterday, there is, once again, a reinvigorated hope for more transformational cystic fibrosis medicines on the horizon. In case you missed it, Sionna is attempting to correct CFTR with a small molecule drug like Vertex’s class of modulators but is targeting a different...
Continue reading...